HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV

CompletedOBSERVATIONAL
Enrollment

2,598

Participants

Timeline

Start Date

March 29, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

August 31, 2023

Conditions
HIV-1-infectionCOVID-19
Interventions
OTHER

COVID-19

Diagnosed with COVID-19 infection

OTHER

HIV-1 infection

Diagnosed with HIV-1 infection

Trial Locations (23)

Unknown

CHU Saint Pierre, Brussels

Hôpital Européen Marseille, Marseille

Hôpital Saint Louis, Paris

Erasmus Medical Center, Rotterdam

Hospital Clinic Barcelona, Barcelona

Hospital de la Santa Creu I Sant Pau, Barcelona

Hospital Universitari de Bellvitge, Barcelona

Hospital Universitario Basurto, Bilbao

Hospital General Universitario de Elche, Elche

Hospital Universitario San Pedro, Logroño

Hospital Ramón y Cajal, Madrid

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario La Paz, Madrid

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

Bradford Teaching Hospitals NHS Foundation Trust, Bradford

Southmead Hospital (North Bristol), Bristol

University Hospitals of Derby & Burton NHS Foundation Trust, Derby

Brownlee Centre, Gartnavel General Hospital, Glasgow

Barts Health (The Royal London Hospital), London

Chelsea & Westminster Hospital NHS Foundation Trust, London

Guy's and St Thomas' NHS Foundation Trust, London

King's College Hospital NHS Foundation Trust, London

Royal Free London NHS Foundation Trust, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

NEAT ID Foundation

OTHER